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Significance of the Study
• Low serum albumin concentration is associated with osteoporosis or low bone mineral density, but its 
link to fractures has not been extensively investigated. In this study, low serum albumin was associ-
ated with an increased risk of long-term fractures in middle-aged Caucasian men, in a linear dose-
response manner. Avoiding low serum albumin levels could help reduce the occurrence of fractures.
DOI: 10.1159/000499738
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Abstract
Objective: Low serum albumin concentration is associated 
with poor health outcomes, but its relationship with the risk 
of fractures has not been reliably quantified. We aimed to 
assess the prospective association of serum albumin with 
the risk of fractures in a general population. Subjects and 
Methods: Baseline serum albumin concentrations were 
measured in 2,245 men aged 42–61 years in the Kuopio Is­
chemic Heart Disease study. Hazard ratios (HRs) (95% confi­
dence intervals) were calculated for incident fractures. Re-
sults: A total of 121 fractures (hip, humeral, or wrist) were 
recorded during a median follow­up of 25.6 years. The risk of 
fractures increased linearly below a serum albumin concen­
tration of ∼48 g/L. The age­adjusted HR (95% CI) for fractures 
per 1 standard deviation lower serum albumin was 1.24 
(1.05–1.48). On further adjustment for several conventional 
and emerging risk factors, the HR was attenuated to 1.21 
(1.01–1.45). Comparing the bottom versus top quartile of se­
rum albumin levels, the corresponding adjusted HRs were 
2.48 (1.37–4.48) and 2.26 (1.23–4.14). The association of se­
rum albumin with fracture risk did not differ substantially 
according to age, body mass index, blood pressure, physical 
activity, alcohol consumption, socioeconomic status, inflam­
mation, prevalent diseases, and smoking. Serum albumin at 
a threshold of 41.5 g/L demonstrated an area under the 
curve of 0.5850. Conclusion: In middle­aged Caucasian men, 
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low serum albumin is associated with an increased risk of 
future fractures. The potential relevance of serum albumin 
concentrations in fracture prevention and prediction de­
serves further evaluation. © 2019 The Author(s)
Published by S. Karger AG, Basel
Introduction
Fractures (particularly osteoporotic fractures) are one 
of the leading worldwide causes of disability among the 
aging population and are associated with high health 
costs [1]. Fractures and their management are associated 
with considerable pain, limited function, morbidity (e.g., 
pneumonia, heart failure), reduction in health-related 
quality of life, as well as mortality [2, 3]. The prevention 
of fractures is an issue of public health importance. There 
is therefore a priority to identify and evaluate risk factors 
(particularly potentially modifiable ones) that may have 
predictive or causal relevance, potentially to help tailor 
preventive and therapeutic strategies. Suggested risk fac-
tors for osteoporotic fractures include advancing age, 
current smoking, high alcohol consumption, glucocorti-
coid therapy, a family history of fracture, as well as de-
creased bone mineral density and occurrence of falls [4, 
5]. Malnutrition has been identified as a risk factor for 
poor outcomes following orthopedic surgery [6]. Low se-
rum albumin concentration, a historical marker of mal-
nutrition [7], has been consistently linked with adverse 
health outcomes such as cardiovascular disease, venous 
thromboembolism, cancer, as well as increased mortality 
[8, 9]. A number of studies have also suggested that low 
serum albumin concentration is associated with func-
tional decline in the elderly [10, 11]. Studies have shown 
that patients with hip fracture are frequently malnour-
ished, indicated by their low serum albumin concentra-
tions [11, 12].
Given the overall evidence, we hypothesized that peo-
ple with low serum albumin concentrations will have an 
increased risk of fractures and may also have risk factors 
that are associated with increased fracture risk. Data on 
the temporal nature of the relationship between serum 
albumin concentrations and fracture risk are limited, as 
the majority of previous studies evaluated serum albu-
min concentrations after fracture occurrence. In the only 
prospective cohort study, which was published over 
three decades ago, Huang et al. [13] demonstrated an in-
verse association between serum albumin and hip frac-
ture risk in a sample of Caucasian women. Drawbacks of 
this study included (a) the inability to account for some 
potential confounders such as preexisting disease, renal 
function, energy intake, trace elements, and inflamma-
tion; (b) the lack of a formal assessment of the shape of 
the relationship between serum albumin and fracture 
risk; hence, it is uncertain whether there is a dose-re-
sponse relationship to the association; and (c) a lack of 
subgroup analysis. 
In this context, we aimed to investigate in greater detail 
than before, the shape, nature, and magnitude of the pro-
spective association between serum albumin and risk of 
future fractures using a population-based cohort of 2,245 
apparently healthy men from eastern Finland. We also 
assessed the consistency of the association in important 
clinical subgroups such as age, body mass index (BMI), 
physical activity, and smoking status. Finally, we deter-
mined the threshold and discriminative utility of serum 
albumin concentration for fractures.
Methods
Study Design and Participants
The analysis employed the Kuopio Ischemic Heart Disease 
(KIHD) study, which is a population-based prospective cohort set 
up to evaluate risk factors for cardiovascular disease and other 
chronic disease outcomes. The cohort, design, and recruitment 
methods have been described previously [14, 15]. Briefly, the 
KIHD cohort is based on a representative sample of 3,433 ran-
domly selected men aged 42–61 years from the city of Kuopio and 
surrounding rural communities in eastern Finland, who were in-
vited for screening examinations between March 1984 and De-
cember 1989. In this analysis, complete information on serum al-
bumin, relevant confounders, and fracture events was available for 
2,245 men. 
Assessment of Serum Albumin and Risk Markers
Baseline assessments involved physical examination, collection 
of blood samples, and the use of self-administered questionnaires. 
Besides fasting overnight before collection of blood samples in the 
morning between 08: 00 and 10: 00 h, participants were also re-
quired to abstain from smoking for at least 12 h and alcohol con-
sumption for at least 3 days prior to blood collection. Serum sam-
ples were stored frozen at –80  ° C for 0.2–2.5 years before measure-
ments were made. Serum albumin concentrations were measured 
using Coulter’s bromocresol purple colorimetric assay (Kone Spe-
cific, Kone Corporation, Espoo, Finland). Serum high-sensitivity 
C-reactive protein (hsCRP) measurements were made with an im-
munometric assay (Immulite High Sensitivity C-Reactive Protein 
Assay; DPC, Los Angeles, CA, USA). The energy expenditure of 
physical activity was assessed using the validated KIHD 12-month 
leisure time physical activity questionnaire [14].
Ascertainment of Incident Fractures 
All incident fractures, representing all hip, humeral, and wrist 
fracture cases that occurred from study entry to 2014, were includ-
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ed. The primary outcome measure assessed was any fracture (de-
fined as hip, humeral, or wrist fractures). Data on incident frac-
tures was collected from the National Hospital Discharge Register 
data by computer linkage using Finnish personal identification 
codes and a comprehensive review of hospital records, discharge 
diagnoses, and inpatient physician claims. Outcome events were 
coded according to the International Classification of Diseases 
Tenth Revision diagnostic codes for fractures by site.
Statistical Analyses
Skewed variables were log-transformed to achieve approxi-
mately symmetrical distributions. Cox proportional hazard re-
gression models were used to conduct time-to-event analyses after 
confirming no major departure from the assumptions of propor-
tionality of hazards, using Schoenfeld residuals. To characterize 
the shape of the association between serum albumin concentra-
tions and fracture risk, we used floating absolute risks as described 
previously [15]. To further explore the shape of the relationship, 
we used a restricted cubic spline with knots at the 5th, 35th, 65th 
and 95th percentiles of serum albumin distribution in a multi-
variate adjusted model. Serum albumin was modelled continu-
ously, per 1 standard deviation (SD) change (per 1 SD decrement) 
in serum albumin levels as the relationship between serum albu-
min and fracture risk was approximately linear. Hazard ratios 
(HRs) were also modelled as quartiles defined according to the 
baseline distribution of serum albumin levels in the sample. The 
HRs were progressively adjusted for (a) age; (b) established risk 
factors and other potential confounders (BMI, systolic blood pres-
sure, history of hypertension, prevalent coronary heart disease, 
smoking status, history of type 2 diabetes, alcohol consumption, 
physical activity, estimated glomerular filtration rate, as calculat-
ed using the Chronic Kidney Disease Epidemiology Collaboration 
formula, socioeconomic status, energy intake, and serum ionized 
calcium); and (c) hsCRP. Given the long follow-up period and 
therefore a high mortality rate which could have hindered our 
primary outcomes, we also performed additional analyses to esti-
mate the baseline cumulative subhazard of fracture considering 
all-cause death as a competing outcome to fracture, using the 
competing risks extension of the Cox proportional hazards mod-
els, as proposed by Fine and Gray [16]. We used the receiver op-
erating characteristic curve to determine the best cutoff point of 
serum albumin which could be used to predict fractures, with the 
predictive accuracy expressed as area under the curve. All statisti-
cal analyses were conducted using Stata version 15 (Stata Corp., 
College Station, TX, USA).
Table 1. Baseline participant characteristics overall and by quartiles of serum albumin
Overall 
(n = 2,245)
Quartile 1 
(n = 603)
Quartile 2 
(n = 537)
Quartile 3 
(n = 568)
Quartile 4 
(n = 537)
p value 
for ANO-
VA
Serum albumin, g/L 42.3 (3.6) 38.0 (2.8) 41.5 (0.5) 43.5 (0.5) 46.5 (1.8)
Questionnaire/Prevalent conditions
Age at survey, years 53.2 (5.0) 53.8 (4.8) 53.3 (4.9) 53.0 (5.0) 52.5 (5.5) <0.001
Alcohol consumption, g/week 31.8 (6.3–92.5) 30.8 (6.6–98.1) 34.8 (5.4–96.1) 29.5 (6.5–88.0) 32.2 (5.1–92.9) 0.669
Total energy intake, kJ/day 9,834 (2,584) 9,958 (2,583) 9,789 (2,484) 10,010 (2,727) 9,557 (2,510) 0.016
Socioeconomic status 8.50 (4.24) 8.62 (4.31) 8.92 (4.12) 8.45 (4.28) 7.99 (4.20) 0.003
History of diabetes 87 (3.9) 24 (4.0) 20 (3.7) 20 (3.5) 23 (4.3) 0.923
Current smokers 714 (31.8) 222 (36.8) 173 (32.2) 186 (32.8) 133 (24.8) <0.01
History of hypertension 680 (30.3) 167 (27.7) 159 (29.6) 177 (31.2) 177 (33.0) 0.255
History of CHD 574 (25.6) 161 (26.7) 157 (29.2) 137 (24.1) 119 (22.2) 0.044
Physical measurements
BMI, kg/m2 26.9 (3.6) 26.7 (3.5) 26.7 (3.5) 26.8 (3.4) 27.4 (3.9) 0.002
SBP, mm Hg 134 (17) 132 (16) 133 (17) 135 (16) 138 (18) <0.001
DBP, mm Hg 89 (10) 87 (10) 88 (10) 89 (10) 90 (11) <0.001
Physical activity, kJ/day 1,204 (627–1,995) 1,185 (651–1,995) 1,108 (613–1,876) 1,195 (610–1,961) 1,290 (655–2,133) 0.595
Lipid markers
Total cholesterol, mmol/L 5.91 (1.07) 6.02 (1.12) 5.92 (1.10) 5.83 (1.01) 5.86 (1.04) 0.012
HDL-C, mmol/L 1.30 (0.30) 1.29 (0.32) 1.28 (0.27) 1.31 (0.31) 1.30 (0.29) 0.475
Metabolic, renal, and inflammatory markers
Fasting plasma glucose, mmol/L 5.36 (1.25) 5.37 (1.49) 5.39 (1.31) 5.32 (1.08) 5.34 (1.06) 0.798
Estimated GFR, mL/min/1.73 m2 86.9 (17.1) 88.1 (18.2) 87.3 (15.9) 86.9 (19.7) 85.3 (13.8) 0.041
High sensitivity CRP, mg/L 1.10 (0.80–1.56) 1.44 (0.79–2.93) 1.38 (0.74–2.52) 1.27 (0.67–2.41) 1.13 (0.67–2.05) <0.001
Trace element
Serum ionized calcium, mmol/L 1.18 (0.05) 1.18 (0.05) 1.18 (0.05) 1.18 (0.05) 1.18 (0.05) 0.08
Values are presented as mean (SD), median (IQR) or n (%). BMI, body mass index; CHD, coronary heart disease; CRP, C-reactive protein; DBP, diastolic 
blood pressure; GFR, glomerular filtration rate; HDL-C, high-density lipoprotein cholesterol; SD, standard deviation; SBP, systolic blood pressure
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Results
Baseline Characteristics
Baseline characteristics of overall study participants 
and by quartiles of serum albumin are summarized in Ta-
ble 1. The mean (SD) age and BMI of study participants 
was 53 (5) years and 26.9 (3.6) kg/m2, respectively. The 
mean (SD) serum albumin level was 42.3 (3.6) g/L. Par-
ticipants in the bottom quartile of serum albumin levels 
were older, more likely to be smokers and have preexist-
ing disease such as coronary heart disease and had higher 
levels of total cholesterol and hsCRP compared with par-
ticipants in quartiles 2–4. Men with a fracture at follow-
up were older and had lower serum albumin levels at 
study entry.
Serum Albumin and Risk of Fractures
During a median follow-up of 25.6 (interquartile 
range, 17.6–27.9) years, 121 fracture events (annual rate 
2.44/1,000 person-years at risk; 95% CI 2.05–2.92) were 
recorded. Serum albumin was approximately linearly as-
sociated with risk of fractures (Fig. 1a). A restricted cubic 
spline curve shows the risk of fractures increasing linear-
ly below a serum albumin concentration of ∼48 g/L 
(p value for nonlinearity = 0.308) and plateaus at a serum 
albumin concentration of ∼40 g/L (Fig. 1b). The HR for 
fractures per 1 SD decrement in serum albumin was 1.24 
(95% CI 1.05–1.48) on adjustment for age which re-
mained unchanged on further adjustment for several es-
tablished risk factors and other potential confounders. 
The association remained consistent on additional ad-
justment for hsCRP 1.21 (95% CI 1.01–1.45). When the 
bottom quartile of serum albumin was compared to the 
top quartile, the corresponding adjusted HRs were 2.48 
(95% CI 1.37–4.48), 2.34 (95% CI 1.28–4.28), and 2.26 
(95% CI 1.23–4.14), respectively (Table 2). A total of 
1,124 all-cause deaths occurred during follow-up. In 
analyses including all-cause death as a competing risk 
event, the corresponding adjusted HRs for fractures were 
2.20 (95% CI 0.96–5.05), 1.96 (95% CI 0.83–4.62), and 
1.92 (95% CI 0.81–4.51), respectively, comparing the bot-
tom quartile to the top quartile of serum albumin levels. 
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Fig. 1. Shapes of the association between serum albumin levels and 
incident fractures. a Shape plotted using floating absolute risks; 
top quartile of serum albumin levels was used as reference. b Re-
stricted cubic spline model of the hazard ratios of composite frac-
ture with serum albumin; restricted cubic spline functions were 
analyzed with knots located at the 5th, 35th, 65th and 95th percen-
tiles of serum albumin distribution (37; 41; 44; and 47.15 g/L) with 
the reference category set at 48 g/L; the dashed lines represent the 
95% confidence intervals. All models were adjusted for age, body 
mass index, systolic blood pressure, history of hypertension, prev-
alent coronary heart disease, smoking status, history of type 2 dia-
betes, alcohol consumption, physical activity, estimated glomeru-
lar filtration rate, socioeconomic status, energy intake, and serum 
ionized calcium.
Serum Albumin and Fractures 5Med Princ Pract
DOI: 10.1159/000499738
Fig. 2. Hazard ratios for baseline levels of serum albumin and fracture risk by several participant level character-
istics. Hazard ratios are adjusted for age, body mass index, systolic blood pressure, history of hypertension, prev-
alent coronary heart disease, smoking status, history of type 2 diabetes, alcohol consumption, physical activity, 
estimated glomerular filtration rate, socioeconomic status, energy intake, and serum ionized calcium. CHD, 
coronary heart disease; CI, confidence interval; HR, hazard ratio; hs, high sensitivity; Q, quartile. * p value for 
interaction; cutoffs used for age, body mass index, systolic blood pressure, physical activity, alcohol consumption, 
socioeconomic status, and high-sensitivity C-reactive protein are median values.
Subgroup Participants, 
n
Fractures,
n
HR (95% CI) p 
value*
Age at survey
<54.4 years 1,201 58 3.28 (1.21, 8.89) 0.500
≥54.4 years 1,044 63 2.30 (1.09, 4.86)
Body mass index
<26.6 kg/m2 1,123 63 2.27 (1.00, 5.13) 0.751
≥26.6 kg/m2 1,122 58 2.41 (1.00, 5.81)
Systolic blood pressure
<132.2 mm Hg 1,130 64 1.89 (0.84, 4.21) 0.718
≥132.2 mm Hg 1,115 57 2.92 (1.20, 7.07)
Physical activity
<1,208 kJ/day 1,123 64 2.53 (1.07, 5.96) 0.801
≥1,208 kJ/day 1,122 57 2.13 (0.92, 4.93)
Alcohol consumption
<31.8 g/week 1,123 54 1.20 (0.54, 2.68) 0.112
≥31.8 g/week 1,122 67 4.97 (1.89, 13.08)
Socioeconomic status
<10 1,255 60 3.18 (1.36, 7.42) 0.531
≥10 990 61 1.65 (0.71, 3.85)
hsC-reactive protein
<1.30 mg/L 1,123 59 2.53 (1.05, 6.12) 0.790
≥1.30 mg/L 1,122 62 2.04 (0.90, 4.62)
History of type 2 diabetes
No 2,158 113 2.51 (1.35, 4.65) 0.029
Yes 87 8 0.58 (0.04, 9.51)
Smoking status
Nonsmokers 1,531 89 1.74 (0.90, 3.36) 0.275
Current smokers 714 32 9.43 (1.24, 71.60)
History of hypertension
No 1,565 83 2.65 (1.25, 5.61) 0.840
Yes 680 38 1.76 (0.63, 4.91)
Prevalent CHD
No 1,671 91 2.51 (1.29, 4.88) 0.127
Yes 574 30 1.81 (0.46, 7.07)
10.02 0.1 0.2 0.6 2 4 8 16 32 84
HR (95% CI) comparing Q1 versus Q4 of serum albumin levels
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Except for evidence of an interaction by prevalent type 2 
diabetes (p for interaction = 0.029), the association be-
tween serum albumin and fracture risk was not signifi-
cantly modified by several clinically relevant characteris-
tics (p for interaction ≥0.10 for each; Fig. 2). The associa-
tion between low serum albumin and increased fracture 
risk was stronger in men without a history of type 2 dia-
betes compared with those with a history of type 2 diabe-
tes. 
The receiver operating characteristic curve showed 
that a serum albumin threshold of 41.5 g/L had 64% 
sensitivity and 50% specificity as a predictive marker 
for fractures. The area under the curve was 0.5850 
(Fig. 3).
Discussion
In this population-based prospective study of middle-
aged Caucasian men, we found low serum albumin levels 
to be associated with an increased risk of any fractures as 
defined by a combined outcome of hip, humeral, and 
wrist fractures. The association seemed to be largely in-
dependent of several conventional and emerging risk fac-
tors. The risk of fractures increased in an approximately 
linear manner at serum albumin concentrations which 
are lower but within normal reference ranges. The asso-
ciation between serum albumin and fracture risk was 
modest when all-cause death was adjusted for as a com-
peting risk event. However, this is not surprising, as se-
rum albumin is independently associated with risk of all-
cause death in our study cohort. The association between 
serum albumin concentration and fracture risk remained 
generally consistent across several clinically relevant sub-
groups, except for evidence of effect modification by a 
history of type 2 diabetes. Finally, our results showed that 
a serum albumin threshold of 41.5 g/L could be used to 
predict fractures; however, the discriminative ability is 
limited.
Various important factors that play a role in bone 
health and influence fracture risk include aging, heritabil-
ity, sex, physical activity, hormonal factors, and nutrition 
[17]. Occurrence of falls and reduced bone mass are also 
major risk factors for osteoporotic fractures [4, 5]. The 
effect of nutrition on bone health and fractures has most-
ly focused on specific dietary factors such as calcium and 
vitamin D, and more recently magnesium [15]. The bio-
logical basis for the strong link between nutritional status 
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Fig. 3. Receiver operator characteristic curve for serum albumin.
Table 2. Association of serum albumin with fractures
Serum albumin Events/
total
Model 1 Model 2 Model 3
HR (95% CI) p value HR (95% CI) p HR (95% CI) p
Per 1 SD decrease 121/2,245 1.24 (1.05–1.48) 0.013 1.22 (1.02–1.47) 0.029 1.21 (1.01–1.45) 0.041
Q1 (10–40 g/L) 42/603 2.48 (1.37–4.48) 0.003 2.34 (1.28–4.28) 0.006 2.26 (1.23–4.14) 0.008
Q2 (41–42 g/L) 36/537 2.47 (1.35–4.52) 0.038 2.24 (1.22–4.12) 0.010 2.18 (1.18–4.01) 0.013
Q3 (43–44 g/L) 28/568 1.94 (1.04–3.64) 0.113 1.84 (0.98–3.47) 0.059 1.81 (0.96–3.41) 0.066
Q4 (45–60 g/L) 15/537 ref ref ref
CI, confidence interval; HR, hazard ratio; ref, reference; Q, quartile; SD, standard deviation. Model 1: adjusted for age. Model 2: model 
1 plus body mass index, systolic blood pressure, history of hypertension (no vs. yes), prevalent coronary heart disease (no vs. yes), 
smoking status (no vs. current), history of type 2 diabetes (no vs. yes), alcohol consumption, physical activity, estimated glomerular 
filtration rate, socioeconomic status, dietary energy intake, and serum ionized calcium. Model 3: model 2 plus high-sensitivity C-reactive 
protein. Except for where indicated, all other confounders were modelled as continuous variables.
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and fracture risk is quite clear. Poor nutritional status and 
deficiencies in nutrients required for bone growth ad-
versely affect the balance between bone formation and 
resorption, which influences bone fragility and results in 
osteoporosis [18]. Poor nutritional status also contributes 
to general bodily weakness, which increases the propen-
sity for falls and subsequent fractures. Though serum al-
bumin is historically considered to be a marker of nutri-
tion [7], the biological pathways linking low serum albu-
min with an increased risk of future fractures is not clear. 
However, albumin is present throughout the bone matrix 
and evidence suggests that circulating albumin may be 
directly involved in fracture development. The underpin-
ning mechanisms postulated include: (a) hypoalbumin-
emia may directly activate osteoclasts and inhibit osteo-
genesis via its relationship with nuclear factor-κB [19]; 
(b) alteration in the metabolism of parathyroid hormone 
and vitamin D binding protein [20]; (c) decreased Gla 
protein resulting in decreased osteoblastic and increased 
osteoclast activities [21]; and (d) albumin has an anabolic 
effect on bone metabolism via its stimulatory effect on 
bone calcium and DNA content [22], hence low serum 
levels may be detrimental to bone. Low serum albumin 
level is also strongly linked to functional decline or out-
comes [10, 11]; it is therefore plausible that low serum 
albumin levels cause an increase in fracture risk via the 
close relationship with functional decline and occurrence 
of falls. Furthermore, low serum albumin may just be an 
indicator of an underlying poor general health and nutri-
tional status [7, 11], which increase the risk of fractures 
[13].
The observed relationship between serum albumin 
and fracture risk may suggest a causal relationship; how-
ever, this remains to be investigated in future studies. The 
current findings, however, do have implications for clin-
ical practice – avoiding low serum albumin concentra-
tions may be a promising strategy for the prevention of 
fractures in the general population. This therapeutic po-
tential has been demonstrated in several previous clinical 
and experimental studies. Serum albumin has been shown 
to enhance the proliferation of stem cells on bone al-
lograft as well as bone healing in a nonunion in human as 
well as animal models [23, 24]. In vitro and in vivo ex-
periments in rat models have shown that serum albumin 
coating of demineralized bone matrix resulted in faster 
and stronger new bone formation [25]. The overall evi-
dence suggests that avoiding low serum albumin levels 
could help reduce the occurrence of fractures. Increasing 
serum albumin concentrations may protect against the 
future risk of fractures; however, well-designed supple-
mentation trials are needed to investigate these potential 
therapeutic implications. Furthermore, trials aimed at 
resolution of the underlying causes of low albumin should 
also be considered.
Our analyses employed a large-scale population-
based prospective cohort study which comprised men 
recruited from the general population; there was com-
plete follow-up for all participants; there was a long fol-
low-up period of over 20 years for the ascertainment of 
outcome data; our analyses were comprehensive, which 
included adjustment for key confounders, assessment of 
the dose-response relationship, and evaluation of the as-
sociation in clinically relevant subgroups; and assay 
measurements for serum albumin measurements which 
employed the bromocresol purple assay, which agrees 
with the gold standard of immunonephelometry [14]. 
There are important caveats about the present study that 
are worthy of mention. First, though participants ab-
stained from smoking for at least 12 h and alcohol con-
sumption for at least 3 days prior to blood collection, 
this was not sufficient to eliminate the influence of long-
term smoking and alcohol consumption on albumin 
levels. However, evidence suggests that alcohol con-
sumption exhibits acute effects by inhibiting albumin 
synthesis [26]. Similarly, acute cigarette smoke seems to 
have a suppressive effect on inflammatory markers [27]. 
Therefore, by abstaining from smoking for at least 12 h 
and alcohol consumption for at least 3 days prior to 
blood collection, any acute effects of smoking and alco-
hol consumption on albumin levels would have been 
minimized, if not eliminated. In addition, our cohort 
employed approximately healthy participants. Finally, 
our analysis adjusted for both smoking and alcohol con-
sumption, thereby minimizing any biases by these fac-
tors. Second, the relatively low event rate did not pro-
vide adequate power which was evidenced by the wide 
confidence intervals and this also precluded sensitivity 
analyses, which would require exclusions. Given this, we 
were also unable to adequately investigate the associa-
tions in specific fracture sites. Third, we only had out-
come data on fractures related to the hip, humerus, and 
wrist and therefore could not assess the associations for 
a broad range of fractures related to osteoporosis. 
Fourth, the present findings cannot be generalized to 
women and other age groups than those included here-
in; however, results from a previous study suggest the 
current findings may be applicable to women [13]. Fifth, 
despite careful adjustment for a comprehensive panel of 
confounders, other potential confounders could have 
been considered such as prevalent conditions (e.g., thy-
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roid disease, Crohn’s disease, celiac disease, myelomas, 
renal disease, liver disease), previous fracture, use of 
medications, and other factors associated with bone 
health such as vitamin D and parathyroid hormone lev-
els. In addition, there was a potential for residual con-
founding by adjusted factors such as dietary factors, 
smoking, and alcohol consumption, due to the lack of 
granular assessment on their frequency, recentness, and 
duration of use. Sixth, we had no data on fractures re-
lated to falls or fall-related hospitalizations. Finally, we 
were unable to correct for regression dilution because of 
absence of repeat measurements of serum albumin, 
which could have underestimated the associations. The 
findings of the present study should be interpreted with 
caution considering these limitations. Further studies 
are indeed needed to replicate this association.
In summary, the association between low serum 
albumin and increased fracture risk in middle-aged 
Caucasian men is consistent with a linear dose-response 
relationship at serum albumin concentrations which 
are lower but within normal reference range. The po-
tential relevance of serum albumin concentrations in 
fracture prevention and prediction deserves further 
evaluation.
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